Safety and effectiveness have not been established for pediatric patients with schizophrenia <13 years of age, for bipolar mania <10 years of age, and for autistic disorder <5 years of age.
[C] = in children.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Risperdal (Ortho-McNeil, Janssen); Risperdal Consta (Ortho-McNeil, Janssen)
- INDICATIONS: Schizophrenia, bipolar mania, irritability associated with autistic disorder
- CLASS: Antipsychotic, Antipsychotic, atypical, Mood stabilizer
- HALF-LIFE: 3–30 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Alcohol, Alpha blockers, Amantadine, Angiotensin II receptor antagonists, Anxiolytics and hypnotics, Apomorphine, Artemether/Lumefantrine, Barbiturates, Bromocriptine, Cabergoline, Calcium channel blockers, Carbamazepine, Cimetidine, Citalopram, Clozapine, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Ethosuximide, Fluoxetine, General anesthetics, Histamine, Levodopa, Memantine, Methyldopa, Metoclopramide, Opioid analgesics, Oxcarbazepine, Paliperidone, Paroxetine Hydrochloride, Pergolide, Phenytoin, Pramipexole, Primidone, Ranitidine, Ritonavir, Ropinirole, Rotigotine, Sodium Oxybate, Sympathomimetics, Tetrabenazine, Tramadol, Tricyclics, Valproic Acid, Viloxazine
- See adverse reactions attributed to class:
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 04/22/2025
